We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMRC icon
2401
Digimarc Corp
DMRC
$168M
$651K ﹤0.01%
20,032
-58
-0.3% -$1.86K
EMBJ
2402
Embraer S.A. ADS
EMBJ
$13.8B
$651K ﹤0.01%
47,414
-420
-0.9% -$6.26K
BBUC
2403
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.94B
$649K ﹤0.01%
35,922
-352
-1% -$6.76K
GCO icon
2404
Genesco
GCO
$432M
$649K ﹤0.01%
21,067
-7,348
-26% -$209K
AVXL icon
2405
Anavex Life Sciences
AVXL
$310M
$649K ﹤0.01%
99,088
-3,050
-3% -$24.3K
CABA icon
2406
Cabaletta Bio
CABA
$455M
$648K ﹤0.01%
42,602
+13,622
+47% +$186K
CECO icon
2407
Ceco Environmental
CECO
$4.05B
$644K ﹤0.01%
40,341
+4,406
+12% +$60.3K
WVE icon
2408
Wave Life Sciences
WVE
$1.2B
$641K ﹤0.01%
111,511
+6,026
+6% +$27.5K
HONE
2409
DELISTED
HarborOne Bancorp
HONE
$640K ﹤0.01%
67,242
-1,387
-2% -$13.5K
TARS icon
2410
Tarsus Pharmaceuticals
TARS
$2.87B
$640K ﹤0.01%
36,006
+544
+2% +$9.63K
CSTL icon
2411
Castle Biosciences
CSTL
$1,000M
$639K ﹤0.01%
37,848
+539
+1% +$9.43K
FMNB icon
2412
Farmers National Banc Corp
FMNB
$930M
$639K ﹤0.01%
55,248
+178
+0.3% +$2.27K
BOC icon
2413
Boston Omaha
BOC
$435M
$639K ﹤0.01%
38,962
+1,169
+3% +$21K
GPRO icon
2414
GoPro
GPRO
$122M
$637K ﹤0.01%
202,741
-328
-0.2% -$1.25K
MLNK
2415
DELISTED
MeridianLink
MLNK
$636K ﹤0.01%
37,253
+477
+1% +$9K
THFF icon
2416
First Financial Corp
THFF
$964M
$635K ﹤0.01%
18,770
+261
+1% +$9.38K
WOW
2417
DELISTED
WideOpenWest
WOW
$634K ﹤0.01%
82,893
-736
-0.9% -$5.84K
ASLE icon
2418
AerSale
ASLE
$267M
$633K ﹤0.01%
42,397
+764
+2% +$11K
ATEX icon
2419
Anterix
ATEX
$1.81B
$633K ﹤0.01%
20,184
-4,054
-17% -$128K
DYN icon
2420
Dyne Therapeutics
DYN
$4.95B
$632K ﹤0.01%
70,571
+6,659
+10% +$71.7K
MITK icon
2421
Mitek Systems
MITK
$818M
$632K ﹤0.01%
58,970
-29,449
-33% -$330K
MNDY icon
2422
monday.com
MNDY
$3.72B
$632K ﹤0.01%
3,968
+638
+19% +$107K
AGTI
2423
DELISTED
Agiliti Inc
AGTI
$628K ﹤0.01%
96,773
+3,935
+4% +$47.7K
SVV icon
2424
Savers
SVV
$1.84B
$627K ﹤0.01%
+33,564
New +$775K
CDNA icon
2425
CareDx
CDNA
$2.47B
$625K ﹤0.01%
89,304
-1,352
-1% -$12.5K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.